...
首页> 外文期刊>Tumour biology : >PKCζ in prostate cancer cells represses the recruitment and M2 polarization of macrophages in the prostate cancer microenvironment
【24h】

PKCζ in prostate cancer cells represses the recruitment and M2 polarization of macrophages in the prostate cancer microenvironment

机译:前列腺癌细胞中的PKCζ抑制前列腺癌微环境中巨噬细胞的募集和M2极化

获取原文

摘要

Tumor-associated macrophages are key regulators of the complex interplay between tumor and tumor microenvironment. M2 Macrophages, one type of tumor-associated macrophages, are involved in prostate cancer growth and progression. Protein kinase C zeta has been shown to suppress prostate cancer cell growth, invasion, and metastasis as a tumor suppressor; however, its role in chemotaxis and activation of tumor-associated macrophages remains unclear. Here, we investigated the role of protein kinase C zeta of prostate cancer cells in regulation of macrophage chemotaxis and M2 phenotype activation. Immunohistochemistry was performed to analyze the expression of protein kinase C zeta and the number of CD206+ M2 macrophages in human prostate tissue. Macrophage chemotaxis and polarization were examined using Transwell migration assays and a co-culture system. Quantitative real-time polymerase chain reaction, western blotting, and enzyme-linked immunosorbent assay were used to detect M2 markers, protein kinase C zeta, interleukin-4, and interleukin-10 expression. We found the expression of protein kinase C zeta increased in prostate cancer tissues, especially in the early stage, and was negatively associated with tumor grade and the number of CD206+ macrophages. Inhibition of protein kinase C zeta expression in prostate cancer cells promoted chemotaxis of peripheral macrophages and acquisition of M2 phenotypic features. These results were further supported by the finding that silencing of endogenous protein kinase C zeta promoted the expression of prostate cancer cell–derived interleukin-4 and interleukin-10. These results suggest that protein kinase C zeta plays an important role in reducing infiltration of tumor-associated macrophages and activation of a pro-tumor M2 phenotype, which may constitute an important mechanism by which protein kinase C zeta represses cancer progression.
机译:肿瘤相关巨噬细胞是肿瘤与肿瘤微环境之间复杂相互作用的关键调节因子。 M2巨噬细胞是一种与肿瘤相关的巨噬细胞,与前列腺癌的生长和进展有关。蛋白激酶C zeta已被证明可以抑制前列腺癌细胞的生长,侵袭和转移,成为一种肿瘤抑制因子。然而,其在趋化性和肿瘤相关巨噬细胞活化中的作用仍不清楚。在这里,我们调查了前列腺癌细胞蛋白激酶C zeta在调节巨噬细胞趋化性和M2表型激活中的作用。进行了免疫组织化学分析人前列腺组织中蛋白激酶C zeta的表达和CD206 + M2巨噬细胞的数量。使用Transwell迁移分析和共培养系统检查巨噬细胞的趋化性和极化。实时定量聚合酶链反应,免疫印迹和酶联免疫吸附测定用于检测M2标记,蛋白激酶C zeta,白介素4和白介素10表达。我们发现蛋白激酶C zeta的表达在前列腺癌组织中增加,尤其是在早期阶段,并且与肿瘤等级和CD206 +巨噬细胞的数量呈负相关。前列腺癌细胞中蛋白激酶C zeta表达的抑制促进外周巨噬细胞的趋化性和M2表型特征的获得。内源性蛋白激酶C zeta沉默可促进前列腺癌细胞衍生的白细胞介素4和白细胞介素10的表达,这一发现进一步支持了这些结果。这些结果表明蛋白激酶C zeta在减少肿瘤相关巨噬细胞的浸润和激活肿瘤前M2表型中起着重要作用,这可能构成蛋白激酶C zeta抑制癌症进展的重要机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号